3 Result: AstraZeneca
Earnings Preview: Key Expectations for AstraZeneca, Nucor, Celestica
July 25th, 2026
LAS VEGAS, NV / CRWE PRESS RELEASE / July 25, 2026 - Several companies are expected to unveil their financial results on Monday, July 27, including: AstraZeneca PLC (NYSE: AZN), the global biopharmaceutical company known for its portfolio of oncol. Read more
AstraZeneca, AMSC, Lifecore Biomedical, Arbor Realty Trust: Biotech News, Bullish Perceptions
June 04th, 2023
AstraZeneca's (Nasdaq: AZN) announced that TAGRISSO (osimertinib) has demonstrated a significant improvement in overall survival (OS) in patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).&nb. Read more
Q1 2023 Earnings Report: KE Holdings and Bath & Body Works Exceed Expectations, Sociedad Química y Minera de Chile Falls Short; Revvity Inks Licensing Deal with AstraZeneca
May 18th, 2023
KE Holdings Inc. (NYSE: BEKE) reported better-than-expected adjusted earnings per share (EPS) for the first quarter of 2023. The company's adjusted EPS stood at $0.43, surpassing the consensus estimate of $0.23. In pre-market trading, $BEKE . Read more
Want To Find Some News?
News By Industries
Recent Post
-
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
August 13th, 2026August 12th, 2026August 11th, 2026For College Athletes, NIL Starts with Reputation
August 11th, 2026Inside the NJCP Player Pathway
August 10th, 2026
Member Login